It is the most common cancer in women in the world, with around 60,000 new cases annually estimated in France. In recent years, we have seen major improvements, from screening to treatment. Epidemiology, risk factors, benefit-risk balance of screening, therapeutic progress, after-effects and return to work after cancer… we offer you a selection of recent articles on the occasion of “Pink October”.
To read:
Hill C. Breast cancer screening: advantages and disadvantages. Rev. Prat (online) May 23, 2024.
Mallordy F. Some common medications affect the prognosis of breast cancer. Rev. Prat (online) April 23, 2024.
Martin Agudelo L. Breast and prostate cancer: NutriNet-Santé points the finger at emulsifiers. Rev. Prat (online) February 15, 2024.
Foucaud J, Bousquet PJ. After cancer: after-effects, return to work and the right to be forgotten. Rev. Prat 2024 ;74(1) ;48 – 51.
Barré-Pierrel S, Fillol F, Derhy S, et al. New developments in cancer screening in France. Rev. Prat 2024 ;74(1) ;40 – 3.
Mallordy F. Breast cancer: increased risk after a false positive mammogram. Rev. Prat (online) November 23, 2023.
Martin Agudelo L. Breast cancer: new findings on RNA assays. Rev. Prat (online) November 22, 2023.
Martin Agudelo L. Breast cancer: should we be screened from the age of 40? Rev. Prat (online) September 29, 2023.
Alexandre M, Jacot W. Therapeutic advances in HER2+ breast cancer. Rev. Prat 2023 ;73(4) :355 – 8.
Martin Agudelo L. Organized breast cancer screening: HAS feedback on mammography. Rev. Prat (online) March 17, 2023.
Mallordy F. Breast cancer diagnosis: AI does better than humans? Rev. Prat (online) January 24, 2023.
Martin Agudelo L. Breast cancer: a major breakthrough! Rev. Prat (online) June 7, 2022.
Martin Agudelo L. Triple negative breast cancer: finally something new! Rev. Prat (online) November 10, 2021.
Triple negative breast cancer: new immunotherapy authorized. Rev. Prat (online) September 7, 2021.
Martin Agudelo L. Postmenopausal breast cancer: pesticides blamed. Rev. Prat (online) March 15, 2021.
Martin Agudelo L. Triple negative breast cancer: the hope of immunotherapy. Rev. Prat (online) February 7, 2021.
Espié M, Cuvier C. Physical activity and breast cancer. Rev. Chat With Gen 2020 ;34(1048) ;701 – 2.
Breast cancer file (excluding metastases), developed according to the scientific advice of Dr Inès Vaz Luis. Rev. Prat 2020 ;70(7) :721 – 47.
Related News :